The antimicrobial peptide Abaecin alleviates colitis in mice by regulating inflammatory signaling pathways and intestinal microbial composition

• Published in: Peptides (New York, N.Y. : 1980) Vol. 173; p. 171154
• Main Authors: Liu, Zhineng, Nong, Keyi, Qin, Xinyun, Fang, Xin, Zhang, Bin, Chen, Wanyan, Wang, Zihan, Wu, Yijia, Shi, Huiyu, Wang, Xuemei, Liu, Youming, Guan, Qingfeng, Zhang, Haiwen
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2024
• Subjects: Abaecin; Intestinal microorganisms; MAPK; NF-κB; Ulcerative colitis; Intestinal microorganisms; NF-κB; MAPK; Abaecin; Ulcerative colitis
• ISSN: 0196-9781; 1873-5169
• DOI: 10.1016/j.peptides.2024.171154

Abaecin is a natural antimicrobial peptide (AMP) rich in proline from bees. It is an important part of the innate humoral immunity of bees and has broad-spectrum antibacterial ability. This study aimed to determine the effect of Abaecin on dextran sulfate sodium (DSS) -induced ulcerative colitis (UC) in mice and to explore its related mechanisms. Twenty-four mice with similar body weight were randomly divided into 4 groups. 2.5% DSS was added to drinking water to induce colitis in mice. Abaecin and PBS were administered rectally on the third, fifth, and seventh days of the experimental period. The results showed that Abaecin significantly alleviated histological damage and intestinal mucosal barrier damage caused by colitis in mice, reduced the concentration of pro-inflammatory cytokines IL-1β, IL-6, TNF-α, IFN-γ, and the phosphorylation of NF-κB / MAPK inflammatory signaling pathway proteins, and improved the composition of intestinal microorganisms. These findings suggest that Abaecin may have potential prospects for the treatment of UC. •Rectal administration of Abaecin relieves DSS-induced ulcerative colitis.•Abaecin alleviates colitis by down-regulating NF-κB/MAPK signalling pathway protein phosphorylation.•Abaecin relieves colitis by improving intestinal flora composition.